Naturalendo Tech Co., Ltd. (KOSDAQ:168330)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,370.00
-20.00 (-1.44%)
Feb 13, 2025, 9:00 AM KST
-38.43%
Market Cap 41.96B
Revenue (ttm) 24.03B
Net Income (ttm) -5.09B
Shares Out 31.57M
EPS (ttm) -161.13
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 17,576
Average Volume 18,677
Open 1,401.00
Previous Close 1,390.00
Day's Range 1,365.00 - 1,419.00
52-Week Range 1,262.00 - 2,845.00
Beta -0.08
RSI 30.62
Earnings Date Mar 19, 2025

About Naturalendo Tech

Naturalendo Tech Co., Ltd. engages in the research, development, manufacturing, and sale of physical chemistry and biology, biological agents, food additives, and health functional food in South Korea. The company offers EstroG-100, a functional raw material for women's menopause; Seoul National University wonder, a diet ingredient; YGF 251, a phyto height growth booster; NET 2401, a multiway sleep-wake cycle regulator; Stauntonia hexaphylla Fruit Extract, an anti-inflammatory superfood; Q.186 complex for improving male menopause; NET 1701, a m... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2001
Employees 74
Stock Exchange KOSDAQ
Ticker Symbol 168330
Full Company Profile

Financial Performance

In 2023, Naturalendo Tech's revenue was 18.79 billion, an increase of 34.69% compared to the previous year's 13.95 billion. Losses were -4.37 billion, -56.68% less than in 2022.

Financial Statements

News

There is no news available yet.